Diagnostic and prognostic biomarker discovery strategies for autoimmune disorders

David Gibson, Joao Banha, Deborah Penque, Luciana Costa, Thomas Conrads, Delores Cahill, John O'Brien, Madeleine Rooney

    Research output: Contribution to journalArticle

    19 Citations (Scopus)

    Abstract

    Current clinical, laboratory or radiological parameters cannot accurately diagnose or predictdisease outcomes in a range of autoimmune disorders. Biomarkers which can diagnose atan earlier time point, predict outcome or help guide therapeutic strategies in autoimmunediseases could improve clinical management of this broad group of debilitating disorders.Additionally, there is a growing need for a deeper understanding of multi-factorialautoimmune disorders.Proteomic platforms offering a multiplex approach are more likely to reflect the complexityof autoimmune disease processes. Findings from proteomic based studies of three distinctautoimmune diseases are presented and strategies compared. It is the authors' view thatsuch approaches are likely to be fruitful in the movement of autoimmune disease treatmentaway from reactive decisions and towards a preventative stand point.
    LanguageEnglish
    Pages1045-1060
    JournalJournal of Proteomics
    Volume73
    DOIs
    Publication statusPublished - 2010

    Fingerprint

    Proteomics
    Autoimmune Diseases
    Biomarkers
    Therapeutics

    Cite this

    Gibson, David ; Banha, Joao ; Penque, Deborah ; Costa, Luciana ; Conrads, Thomas ; Cahill, Delores ; O'Brien, John ; Rooney, Madeleine. / Diagnostic and prognostic biomarker discovery strategies for autoimmune disorders. In: Journal of Proteomics. 2010 ; Vol. 73. pp. 1045-1060.
    @article{690aabcf65a1455a8063db70ed9c77a6,
    title = "Diagnostic and prognostic biomarker discovery strategies for autoimmune disorders",
    abstract = "Current clinical, laboratory or radiological parameters cannot accurately diagnose or predictdisease outcomes in a range of autoimmune disorders. Biomarkers which can diagnose atan earlier time point, predict outcome or help guide therapeutic strategies in autoimmunediseases could improve clinical management of this broad group of debilitating disorders.Additionally, there is a growing need for a deeper understanding of multi-factorialautoimmune disorders.Proteomic platforms offering a multiplex approach are more likely to reflect the complexityof autoimmune disease processes. Findings from proteomic based studies of three distinctautoimmune diseases are presented and strategies compared. It is the authors' view thatsuch approaches are likely to be fruitful in the movement of autoimmune disease treatmentaway from reactive decisions and towards a preventative stand point.",
    author = "David Gibson and Joao Banha and Deborah Penque and Luciana Costa and Thomas Conrads and Delores Cahill and John O'Brien and Madeleine Rooney",
    year = "2010",
    doi = "10.1016/j.jprot.2009.11.013",
    language = "English",
    volume = "73",
    pages = "1045--1060",
    journal = "Journal of Proteomics",
    issn = "1874-3919",
    publisher = "Elsevier",

    }

    Gibson, D, Banha, J, Penque, D, Costa, L, Conrads, T, Cahill, D, O'Brien, J & Rooney, M 2010, 'Diagnostic and prognostic biomarker discovery strategies for autoimmune disorders', Journal of Proteomics, vol. 73, pp. 1045-1060. https://doi.org/10.1016/j.jprot.2009.11.013

    Diagnostic and prognostic biomarker discovery strategies for autoimmune disorders. / Gibson, David; Banha, Joao; Penque, Deborah; Costa, Luciana; Conrads, Thomas; Cahill, Delores; O'Brien, John; Rooney, Madeleine.

    In: Journal of Proteomics, Vol. 73, 2010, p. 1045-1060.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - Diagnostic and prognostic biomarker discovery strategies for autoimmune disorders

    AU - Gibson, David

    AU - Banha, Joao

    AU - Penque, Deborah

    AU - Costa, Luciana

    AU - Conrads, Thomas

    AU - Cahill, Delores

    AU - O'Brien, John

    AU - Rooney, Madeleine

    PY - 2010

    Y1 - 2010

    N2 - Current clinical, laboratory or radiological parameters cannot accurately diagnose or predictdisease outcomes in a range of autoimmune disorders. Biomarkers which can diagnose atan earlier time point, predict outcome or help guide therapeutic strategies in autoimmunediseases could improve clinical management of this broad group of debilitating disorders.Additionally, there is a growing need for a deeper understanding of multi-factorialautoimmune disorders.Proteomic platforms offering a multiplex approach are more likely to reflect the complexityof autoimmune disease processes. Findings from proteomic based studies of three distinctautoimmune diseases are presented and strategies compared. It is the authors' view thatsuch approaches are likely to be fruitful in the movement of autoimmune disease treatmentaway from reactive decisions and towards a preventative stand point.

    AB - Current clinical, laboratory or radiological parameters cannot accurately diagnose or predictdisease outcomes in a range of autoimmune disorders. Biomarkers which can diagnose atan earlier time point, predict outcome or help guide therapeutic strategies in autoimmunediseases could improve clinical management of this broad group of debilitating disorders.Additionally, there is a growing need for a deeper understanding of multi-factorialautoimmune disorders.Proteomic platforms offering a multiplex approach are more likely to reflect the complexityof autoimmune disease processes. Findings from proteomic based studies of three distinctautoimmune diseases are presented and strategies compared. It is the authors' view thatsuch approaches are likely to be fruitful in the movement of autoimmune disease treatmentaway from reactive decisions and towards a preventative stand point.

    U2 - 10.1016/j.jprot.2009.11.013

    DO - 10.1016/j.jprot.2009.11.013

    M3 - Article

    VL - 73

    SP - 1045

    EP - 1060

    JO - Journal of Proteomics

    T2 - Journal of Proteomics

    JF - Journal of Proteomics

    SN - 1874-3919

    ER -